You are currently viewing a new version of our website. To view the old version click .
Symmetry
  • This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
  • Article
  • Open Access

3 January 2026

Modeling the Dynamic of Herpes Simplex Virus II Incorporating Voluntary Laboratory Test and Medical Treatment

,
,
,
,
and
1
Department of Mathematics, Faculty of Physical Science, Modibbo Adama University, Yola 640261, Adamawa, Nigeria
2
Department of Statistics, Ramat Polytechnic, Maiduguri 600251, Borno, Nigeria
3
Department of Mathematics, Federal University, Wukari 670101, Taraba State, Nigeria
4
Department of Mathematics, Faculty of Natural and Applied Sciences, Sule Lamido University Kafin Hausa, Kafin Hausa 741103, Jigawa State, Nigeria
Symmetry2026, 18(1), 86;https://doi.org/10.3390/sym18010086 
(registering DOI)
This article belongs to the Special Issue New Trends on the Mathematical Models and Solitons Arising in Real-World Problems, 3rd Edition

Abstract

This study develops a mathematical model to investigate the transmission dynamics of HSV-II within the framework of symmetry in dynamical systems. The basic reproduction number (R0HSV<1) of the model was determined using the next generation method (NGM). The stability of the disease-free equilibrium point was also investigated using the Routh–Hurwitz Criterion and was found to be locally asymptotically stable (LAS) when R0HSV<1 but not globally asymptotically stable (GAS). To help ensure that the control variables were included correctly, sensitivity analysis was performed on the fundamental reproduction number parameters. Four control variables were applied for the model: HSV-II vaccination, effective condom use, laboratory test, and treatment. The optimality system was solved using Pontryagin’s maximum principle (PMP) to establish the optimal control strategy for combating the spread of the disease. Numerical solution was obtained by using the forward-backward Runge–Kutta fourth-order approach. The most effective approach to help eradicate HSV-II disease in the system is to combine the HSV-II vaccine, effective condom use, laboratory testing, and HSV therapy (strategy D).

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.